|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of Homo sapiens lysosomal-associated membrane protein 1 DNA.|
|LAMPA, CD107a, LGP120, LAMP1|
|pMD18-T Simple Vector|
|Identical with the Gene Bank Ref. ID sequence except for two point mutation: 6 G/T and 556 C/A not causing the amino acid variation.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
pMD18-T Simple Vector is a high-efficiency TA cloning vector constructed from pUC18, of which the initial multiple cloning sites (MCS) were destroyed. Thus the cDNA should be amplified by PCR with primers containing a restriction site for subclone. Competent cells appropriate for pUC18 are also appropriated for the Vector, e.g. JM109, DH5α, TOP10. The pMD18-T Simple Vector is 2.6kb in size. Selection of the plasmid in E. coli is conferred by the ampicillin resistance gene. The coding sequence was inserted by TA cloning at site 425.
The coding sequence can be amplified by PCR with M13-47 and RV-M primers.
|Human LAMP-1 / CD107a / LAMP1 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||HG11215-M-F|
|Human LAMP-1 / CD107a / LAMP1 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||HG11215-M-H|
|Human LAMP-1 / CD107a / LAMP1 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||HG11215-M-M|
|Human LAMP-1 / CD107a / LAMP1 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||HG11215-M-N|
|Human LAMP-1 / CD107a / LAMP1 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||HG11215-M-Y|
|Product name||Product name|
Lysosome-associated membrane glycoprotein 1, also known as CD107 antigen-like family member A, CD107a, and LAMP1, is a single-pass type I membrane protein which belongs to the LAMP family. CD107a is expressed largely in the endosome-lysosome membranes of cells, but is also found on the plasma membrane (1-2% of total LAMP1). LAMP1 has been implicated in a variety of cellular functions, including cancer metastasis. It has been proposed LAMP1 serves as a therapeutic agent for some cancers, as well as a marker for lysosomal storage disorders and different cell types such as cytotoxic T cells. LAMP2, also known as CD107b, may also play a role in tumor cell metastasis and functions in the protection, maintenance, and adhesion of the lysosome. Cell surface LAMP1 and LAMP2 have been shown to promote adhesion of human peripheral blood mononuclear cells (PBMC) to vascular endothelium, therefore they are possibly involved in the adhesion of PBMCs to the site of inflammation. LAMP-1 is a glycoprotein highly expressed in lysosomal membranes. The present study was initiated to test LAMP-1 mRNA and protein levels in post mortem frontal cortex (area 8) of Alzheimer's disease (AD) stages I-IIA/B and stages V-VIC of Braak and Braak, compared with age-matched controls. LAMP-1 occurred in microglia and multinucleated giant cells in one AD case in whom amyloid burden was cleared following betaA-peptide immunization. In addition, LAMP-1 has been suggested to be a cell surface receptor for a specific amelogenin isoform, leucine-rich amelogenin peptide or LRAP. LAMP-1 can serve as a cell surface binding site for amelogenin on dental follicle cells and cementoblasts.